Opsoclonus-myoclonus syndrome: a clinicopathological confrontation

被引:0
|
作者
Baets, J.
Pals, P.
Bergmans, B.
Foncke, E.
Smets, K.
Hauman, H.
Vanderwegen, L.
Cras, P.
机构
[1] Univ Antwerp, Dept Neurol, Born Bunge Fdn, Lab Neurobiol & Neuropathol, B-2610 Antwerp, Belgium
[2] Heilig Hartziekenhuis, Dept Neurol, Lier, Belgium
[3] St Maarten Gen Hosp, Dept Neurol, Duffel, Belgium
[4] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium
关键词
paraneoplastic syndrome; breast carcinoma; NSCLC; immunoglobulins; plasmapheresis;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Opsoclonus-myoclonus syndrome (OMS), a movement disorder characterised by chaotic eye movements and myoclonus, is a rare clinical entity. We present two cases of opsoclonus-myoclonus syndrome of paraneoplastic origin. In the first patient the syndrome was associated with a breast carcinoma and in the second patient with a non small cell lung carcinoma. However none of the commonly associated antibodies were found in these cases. From the neuropathological findings from the first patient we find arguments that support the current hypothesis on the pathophysiology of OMS namely a dysfunction in brainstem and cerebellum. We conclude that in adults with OMS one has to be very suspicious of a possible neoplastic origin of the syndrome. The antibodies associated with some cases of OMS are thought to play a role in the pathophysiology of the syndrome although the exact immunologic mechanism remains unknown. Research into the neuropathological substrate of OMS yields a broad range of abnormalities in brain stem and cerebellum. However none of these findings seem to be pathognomonic. As for the possible therapy of OMS, several immunomodulating strategies can be used with varying success. At present there is no established standard therapy.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 50 条
  • [41] Opsoclonus-myoclonus syndrome in a patient with an anaplastic oligoastrocytoma
    Gold, Carl A.
    Lassman, Andrew B.
    Odia, Yazmin
    JOURNAL OF NEURO-ONCOLOGY, 2015, 123 (02) : 315 - 316
  • [42] Opsoclonus-myoclonus syndrome secondary to duloxetine poisoning
    Trigo Lopez, J.
    Martinez Pias, E.
    Carrancho Garcia, A.
    Pedraza Hueso, M. I.
    NEUROLOGIA, 2021, 36 (03): : 250 - 252
  • [43] Rituximab treatment for relapsed opsoclonus-myoclonus syndrome
    Toyoshima, Daisaku
    Morisada, Naoya
    Takami, Yuichi
    Kidokoro, Hiroyuki
    Nishiyama, Masahiro
    Nakagawa, Taku
    Ninchoji, Takeshi
    Nozu, Kandai
    Takeshima, Yasuhiro
    Takada, Satoshi
    Nishio, Hisahide
    Iijima, Kazumoto
    BRAIN & DEVELOPMENT, 2016, 38 (03): : 346 - 349
  • [44] Methotrexate: A new treatment in opsoclonus-myoclonus syndrome
    Denne, Christian
    Kleines, Michael
    Scheithauer, Simone
    Heimann, Gerhard
    Haeusler, Martin
    JOURNAL OF PEDIATRIC NEUROLOGY, 2006, 4 (03) : 183 - 185
  • [45] New Findings in Adult Opsoclonus-Myoclonus Syndrome
    Honnorat, Jerome
    JAMA NEUROLOGY, 2016, 73 (04) : 381 - 382
  • [46] Adult-Onset Opsoclonus-Myoclonus Syndrome
    Klaas, James P.
    Ahlskog, J. Eric
    Pittock, Sean J.
    Matsumoto, Joseph Y.
    Aksamit, Allen J.
    Bartleson, J. D.
    Kumar, Rajeev
    McEvoy, Kathleen F.
    McKeon, Andrew
    ARCHIVES OF NEUROLOGY, 2012, 69 (12) : 1598 - 1607
  • [47] Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome
    Yiu, VWY
    Kovithavongs, T
    McGonigle, LF
    Ferreira, P
    PEDIATRIC NEUROLOGY, 2001, 24 (01) : 72 - 74
  • [48] Adult-Onset Opsoclonus-Myoclonus Syndrome
    Klaas, James
    Kumar, Rajeev
    Ahlskog, J.
    Matsumoto, Joseph
    Pittock, Sean
    Lennon, Vanda
    Bartleson, J. D.
    McEvoy, Kathleen
    Aksamit, Allen
    McKeon, Andrew
    NEUROLOGY, 2012, 78
  • [49] Opsoclonus-myoclonus syndrome after adenovirus infection
    Syrbe, Steffen
    Merkenschlager, Andreas
    Bernhard, Matthias K.
    Grosche, Jens
    Liebert, Uwe Gerd
    Hirsch, Wolfgang
    Hartig, Wolfgang
    SPRINGERPLUS, 2015, 4
  • [50] Sensory trick in patients with opsoclonus-myoclonus syndrome
    Komatsuda, Hiroki
    Kumai, Takumi
    Kishibe, Kan
    Sawada, Jun
    Kanaya, Takeshi
    ACTA NEUROLOGICA BELGICA, 2023, 123 (06) : 2353 - 2355